Dover has entered into a definitive settlement to acquire Malema Engineering Corp, a US designer and producer of high-precision, mission-critical flow-measurement and management devices for the biopharmaceutical, semiconductor and industrial sectors.
Image: dizain/Adobe Stock.
เพรสเชอร์เกจnuovafima will expand Dover’s biopharma single-use manufacturing providing, which already contains Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with facilities in San Jose, California, Singapore, South Korea and India, Malema expects to generate roughly US$40 million–45 million in income in the course of the full yr 2022.
When the deal closes, Malema will turn into a part of the PSG business unit inside Dover’s Pumps & Process Solutions section.
“We see an amazing long-term progress opportunity within the bioprocessing trade driven by a strong and growing pipeline of efficient novel biologic medicine, biosimilars, protein therapies, non-COVID mRNA vaccines, in addition to budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the rising adoption of more efficient single-use manufacturing processes supports a robust outlook for our choices of single-use components to end-customers. We believe that pairing Malema’s technology with our existing portfolio of single-use pumps for biopharma processing will tremendously enhance the accuracy and value proposition of our solutions to our clients.”
“We are methodically building out our biopharma platform via proactive capacity additions, new product development, and opportunistic acquisitions of highly-attractive niche element applied sciences,” stated Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing know-how and further strengthens our sensor portfolio with new proprietary technology. In addition to attractive biopharma functions, we anticipate sturdy progress within the semiconductor area on the capability growth and re-shoring tailwinds.”
Share